Supporting Information

Size: px
Start display at page:

Download "Supporting Information"

Transcription

1 Supporting Information Decoding Allosteric Networks in Biocatalysts: Rational Approach to Therapies and Biotechnologies Johannes T. Cramer 1,2, Jana I. Führing 1, Petra Baruch 2, Christian Brütting 3, Hans-Joachim Knölker 3 *, Rita Gerardy-Schahn 1 and Roman Fedorov 2 * 1 Institute of Clinical Biochemistry, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover, Germany 2 Institute for Biophysical Chemistry / Research Division for Structural Biochemistry, Hannover Medical School, Carl-Neuberg-Strasse 1, Hannover, Germany 3 Department of Chemistry, Technische Universität Dresden, Bergstrasse 66, Dresden, Germany Corresponding Authors * Fedorov.Roman@mh-hannover.de * hans-joachim.knoelker@tu-dresden.de S1

2 Table of Contents Supporting Tables... 3 Table S Table S Supporting Figures... 5 Figure S Figure S Figure S Figure S Figure S Figure S Figure S Figure S Figure S Figure S S2

3 Supporting Tables Table S1 LmUGP mutant crystal structure statistics LmUGP mutant V402W S374W S374F G45Y PDB-code 5NZH 5NZG 5NZI 5NZJ Crystal parameters Space group C 2 C C C Cell parameters: a, b, c[å], α, β, γ[ ] 179.6, 70.9, 112.3, 90, 123.5, , 89.8, 137.3, 90, 90, , 88.2, 137.4, 90, 90, , 87.7, 138.1, 90, 90, 90 Data collection Beamline Petra III P11 ESRF ID29 ESRF ID29 ESRF ID23-2 Wavelength [Å] Crystal mosaicity[ ] Wilson B-factor [Å 2 ] Resolution range (total/high)[å] / / / / Unique reflections (total/high) 26,339/2,510 78,616/13,410 30,193/3,929 35,684/4,915 Completeness (total/high) [%] 100.0/ / / /100 (I/σ(I)) (total/high) 4.37/ / / /2.25 Rsigma (total/high) % 18.3/ / / /45.5 Rint (total/high) % 26.3/ / / /76.3 Refinement statistics Included amino acids Protein atoms 7,465 3,731 3,731 3,731 H2O molecules Rwork/Rfree % 22.5/ / / /21.5 RMSD bonds [Å]/angles [ ] 0.007/ / / /1.314 S3

4 Table S2 LmUGP complex crystal structure statistics LmUGP complex Phenylalanine Resveratrol Murrayamine-I PDB-code 5NZK 5NZL 5NZM Crystal parameters Group C C P43 Cell parameters: a, b, c[å], α, β, γ[ ] 72.66, , , 90, 90, , , , 90, 90, , 95.11, 72.67, 90, 90, 90 Data collection ESRF beamline ID29 ID23-2 ID30B wavelength [Å] Crystal mosaicity [ ] Wilson B-factor [Å 2 ] resolution range (total/high)[ Å] / / / unique reflections (total/high) 22,170/2,219 24,020/2,733 27,167/3,182 completeness (total/high) % 100/ / /99.9 (I/σ(I)) (total/high) 17.27/ / /2.38 Rsigma (total/high) % 3.7/ / /40.1 Rint (total/high) % 9.8/ / /73.0 Refinement statistics included amino acids Protein atoms 3,731 3,731 3,731 H2O molecules Rwork/Rfree % 19.4/ / /22.4 RMSD bonds [Å]/angles [ ] 0.014/ / /0.663 S4

5 Supporting Figures Figure S1 LmUGP activities (A) LmUGP allosteric pocket mutant activities compared to the wild-type. (B) Effect of 600 µm resveratrol or phenylalanine on LmUGP activity. S5

6 Figure S2. Electron density omit map around murrayamine-i in allosteric pocket 1 of LmUGP shown in three orientations. S6

7 Figure S3 (A) Pharmacophore representation of pocket 1. Hydrophobic patches are shown in black, hydrogen bond donors and acceptors in blue and red, respectively. (B) Molecular scaffold for a model of pocket 1 inhibitor resulting from in silico and in crystal molecular fragment screening. (C) X-ray crystal structure of LmUGP phenylalanine complex. (D) X-ray crystal structure of LmUGP resveratrol complex. The color scheme used for the protein surface on panels (C) and (D) is the same as in Figure 1A of the main text. S7

8 Figure S4 (A) Superposition of LmUGP (green, red, magenta, grey) and hugp (black, blue) demonstrates highly conserved structures of the catalytic domains and active sites of the host and the pathogen s enzymes. At the same time, the lock region in LmUGP (grey) has significant differences from the corresponding area in hugp (blue). (B) Superposition of the lock region of LmUGP in the open (apo) and closed (post-reactive) states (grey and blue colors, respectively). The large-scale conformational change of the lock is essential for the stabilization of Glc-1P substrate and its optimal positioning for the catalytic reaction. S8

9 Figure S5 Kinetics for LmUGP V402W mutant. Depicted is the activity, dependent on UTP- or Glc-1P concentration and the resulting Km for both substrates. S9

10 Figure S6 X-ray crystal structure of LmUGP V402W mutant. (A) Overview and (B) close-up view of LmUGP in surface representation with the W402 surface in cyan. The color scheme used for the protein surface is the same as in Figure 1A of the main text. (C) Superposition of V402W mutant (black) and the wild-type (colored) structures. The semitransparent molecular surface shows the steric hindrance effect of tryptophan in pocket 1. (D) 2F o F c electron density omit map for W402 and (E) the active site lacking UDP-Glc. S10

11 Figure S7 X-ray crystal structure of LmUGP S374W mutant. (A) Overview and (B) close-up view of LmUGP in surface representation with the W374 surface in cyan. The color scheme used for the protein surface is the same as in Figure 1A of the main text. (C) 2F o F c electron density omit map for W374 and (D) UDP-Glc in the active site. S11

12 Figure S8 X-ray crystal structure of LmUGP S374F mutant. (A) Overview and (B) close-up view of LmUGP in surface representation with the F374 surface in cyan. The color scheme used for the protein surface is the same as in Figure 1A of the main text. (C) 2F o F c electron density omit map for F374 and (D) UDP-Glc in the active site. S12

13 Figure S9 X-ray crystal structure of LmUGP G45Y mutant. (A) Overview and (B) close-up view of LmUGP in surface representation with the G45 surface in cyan. The color scheme used for the protein surface is the same as in Figure 1A of the main text. (C) 2F o F c electron density omit map for G45 and (D) UDP-Glc in the active site. S13

14 Figure S10 The flow chart summarizing a rational approach to identify, analyze, validate and target specific allosteric regulation sites in biocatalysts with conserved catalytic centers. S14

Supplementary Information. The protease GtgE from Salmonella exclusively targets. inactive Rab GTPases

Supplementary Information. The protease GtgE from Salmonella exclusively targets. inactive Rab GTPases Supplementary Information The protease GtgE from Salmonella exclusively targets inactive Rab GTPases Table of Contents Supplementary Figures... 2 Supplementary Figure 1... 2 Supplementary Figure 2... 3

More information

IgE binds asymmetrically to its B cell receptor CD23

IgE binds asymmetrically to its B cell receptor CD23 Supplementary Information IgE binds asymmetrically to its B cell receptor CD23 Balvinder Dhaliwal 1*, Marie O. Y. Pang 2, Anthony H. Keeble 2,3, Louisa K. James 2,4, Hannah J. Gould 2, James M. McDonnell

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature11085 Supplementary Tables: Supplementary Table 1. Summary of crystallographic and structure refinement data Structure BRIL-NOP receptor Data collection Number of crystals 23 Space group

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature11539 Supplementary Figure 1 Schematic representation of plant (A) and mammalian (B) P 2B -ATPase domain organization. Actuator (A-), nucleotide binding (N-),

More information

Receptor Based Drug Design (1)

Receptor Based Drug Design (1) Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Fig. 1 Influences of crystal lattice contacts on Pol η structures. a. The dominant lattice contact between two hpol η molecules (silver and gold) in the type 1 crystals. b. A close-up view of the hydrophobic

More information

Supplemental Information. Molecular Basis of Spectral Diversity. in Near-Infrared Phytochrome-Based. Fluorescent Proteins

Supplemental Information. Molecular Basis of Spectral Diversity. in Near-Infrared Phytochrome-Based. Fluorescent Proteins Chemistry & Biology, Volume 22 Supplemental Information Molecular Basis of Spectral Diversity in Near-Infrared Phytochrome-Based Fluorescent Proteins Daria M. Shcherbakova, Mikhail Baloban, Sergei Pletnev,

More information

CH 3 CH 2 OH +H 2 O CHO. 2e + 2H + + O 2 H 2 O +HCOOH

CH 3 CH 2 OH +H 2 O CHO. 2e + 2H + + O 2 H 2 O +HCOOH 2 4 H CH 3 2e + 2H + + 2 H 2 2 H CH 2 H 2e + 2H + + 2 H 2 2 H +H 2 CH 2e + 2H + + 2 H 2 2 H +HCH Supplemental Figure S. The three-step 4DM reaction, each step requires two reducing equivalents from ADPH

More information

Design of Enzyme Literature Seminar Yun-wei Xue

Design of Enzyme Literature Seminar Yun-wei Xue Design of Enzyme 20180714 Literature Seminar Yun-wei Xue 1 Contents 1. Introduction 2. De novo design 3. Incorporation of unnatural amino acid (main paper) 2 1.1 Advantages and limitations of natural enzyme

More information

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland

Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland Supporting information Twenty crystal structures of bromodomain and PHD finger containing protein 1 (BRPF1)/ligand complexes reveal conserved binding motifs and rare interactions Jian Zhu and Amedeo Caflisch*

More information

A conserved P-loop anchor limits the structural dynamics that mediate. nucleotide dissociation in EF-Tu.

A conserved P-loop anchor limits the structural dynamics that mediate. nucleotide dissociation in EF-Tu. Supplemental Material for A conserved P-loop anchor limits the structural dynamics that mediate nucleotide dissociation in EF-Tu. Evan Mercier 1,2, Dylan Girodat 1, and Hans-Joachim Wieden 1 * 1 Alberta

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:1.138/nature1737 Supplementary Table 1 variant Description FSEC - 2B12 a FSEC - 6A1 a K d (leucine) c Leucine uptake e K (wild-type like) K (Y18F) K (TS) K (TSY) K288A mutant, lipid facing side chain

More information

Structural Insights from Molecular Dynamics. Simulations of Tryptophan 7-Halogenase and

Structural Insights from Molecular Dynamics. Simulations of Tryptophan 7-Halogenase and Supporting Information Structural Insights from Molecular Dynamics Simulations of Tryptophan 7-Halogenase and Tryptophan 5-halogenase Jon Ainsley 1, Adrian J. Mulholland 2, Gary W. Black 1, Olivier Sparagano

More information

Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA 30144 Dept. Chem. & Biochem. Kennesaw

More information

Targeting protein-protein interactions: A hot topic in drug discovery

Targeting protein-protein interactions: A hot topic in drug discovery Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,

More information

SI Text S1 Solution Scattering Data Collection and Analysis. SI references

SI Text S1 Solution Scattering Data Collection and Analysis. SI references SI Text S1 Solution Scattering Data Collection and Analysis. The X-ray photon energy was set to 8 kev. The PILATUS hybrid pixel array detector (RIGAKU) was positioned at a distance of 606 mm from the sample.

More information

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:

More information

Biophysics 490M Project

Biophysics 490M Project Biophysics 490M Project Dan Han Department of Biochemistry Structure Exploration of aa 3 -type Cytochrome c Oxidase from Rhodobacter sphaeroides I. Introduction: All organisms need energy to live. They

More information

Nitrogenase MoFe protein from Clostridium pasteurianum at 1.08 Å resolution: comparison with the Azotobacter vinelandii MoFe protein

Nitrogenase MoFe protein from Clostridium pasteurianum at 1.08 Å resolution: comparison with the Azotobacter vinelandii MoFe protein Acta Cryst. (2015). D71, 274-282, doi:10.1107/s1399004714025243 Supporting information Volume 71 (2015) Supporting information for article: Nitrogenase MoFe protein from Clostridium pasteurianum at 1.08

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Structure of human carbamoyl phosphate synthetase: deciphering the on/off switch of human ureagenesis Sergio de Cima, Luis M. Polo, Carmen Díez-Fernández, Ana I. Martínez, Javier

More information

Experimental and Computational Mutagenesis to Investigate the. Positioning of a General Base within an Enzyme Active Site

Experimental and Computational Mutagenesis to Investigate the. Positioning of a General Base within an Enzyme Active Site Experimental and Computational Mutagenesis to Investigate the Positioning of a General Base within an Enzyme Active Site Jason P. Schwans, Philip Hanoian, Benjamin J. Lengerich, Fanny Sunden, Ana Gonzalez

More information

SUPPORTING INFORMATION

SUPPORTING INFORMATION SUPPORTING INFORMATION Discovery of a potent class I PRMT fragment inhibitor Renato Ferreira de Freitas 1,$, Mohammad S. Eram 1,$, Magdalena M. Szewczyk 1, Holger Steuber 2, David Smil 1, Hong Wu 1, Fengling

More information

Plasmid Relevant features Source. W18N_D20N and TrXE-W18N_D20N-anti

Plasmid Relevant features Source. W18N_D20N and TrXE-W18N_D20N-anti Table S1. E. coli plasmids Plasmid Relevant features Source pdg680 T. reesei XynII AA 2-190 with C-terminal His 6 tag optimized for E. coli expression in pjexpress401 Wan et al. (in press) psbn44d psbn44h

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature11054 Supplementary Fig. 1 Sequence alignment of Na v Rh with NaChBac, Na v Ab, and eukaryotic Na v and Ca v homologs. Secondary structural elements of Na v Rh are indicated above the

More information

Structure, mechanism and ensemble formation of the Alkylhydroperoxide Reductase subunits. AhpC and AhpF from Escherichia coli

Structure, mechanism and ensemble formation of the Alkylhydroperoxide Reductase subunits. AhpC and AhpF from Escherichia coli Structure, mechanism and ensemble formation of the Alkylhydroperoxide Reductase subunits AhpC and AhpF from Escherichia coli Phat Vinh Dip 1,#, Neelagandan Kamariah 2,#, Malathy Sony Subramanian Manimekalai

More information

Tutorial: Structural Analysis of a Protein-Protein Complex

Tutorial: Structural Analysis of a Protein-Protein Complex Molecular Modeling Section (MMS) Department of Pharmaceutical and Pharmacological Sciences University of Padova Via Marzolo 5-35131 Padova (IT) @contact: stefano.moro@unipd.it Tutorial: Structural Analysis

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature11744 Supplementary Table 1. Crystallographic data collection and refinement statistics. Wild-type Se-Met-BcsA-B SmCl 3 -soaked EMTS-soaked Data collection Space

More information

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 03

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 03 01) Which of the following statements is not true regarding the active site of an enzyme? a. An active site is normally on the surface of an enzyme. b. An active site is normally hydrophobic in nature.

More information

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1

Nature Structural & Molecular Biology: doi: /nsmb Supplementary Figure 1 Supplementary Figure 1 Crystallization. a, Crystallization constructs of the ET B receptor are shown, with all of the modifications to the human wild-type the ET B receptor indicated. Residues interacting

More information

[Urea] (M) k (s -1 )

[Urea] (M) k (s -1 ) BMB178 Fall 2018 Problem Set 1 Due: 10/26/2018, noon Office hour: 10/25/2018, SFL GSR218 7 9 pm Problem 1. Transition state theory (20 points): Consider a unimolecular reaction where a substrate S is converted

More information

SUPPLEMENTARY FIGURES. Figure S1

SUPPLEMENTARY FIGURES. Figure S1 SUPPLEMENTARY FIGURES Figure S1 The substrate for DH domain (2R,3R,4R,6R,7S,8S,9R)-3,7,9-trihydroxy-5-oxo-2,4,6,8 tetramethylundecanoate) was docked as two separate fragments shown in magenta and blue

More information

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017 Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature10955 Supplementary Figures Supplementary Figure 1. Electron-density maps and crystallographic dimer structures of the motor domain. (a f) Stereo views of the final electron-density maps

More information

Supporting Information

Supporting Information Supporting Information Ottmann et al. 10.1073/pnas.0907587106 Fig. S1. Primary structure alignment of SBT3 with C5 peptidase from Streptococcus pyogenes. The Matchmaker tool in UCSF Chimera (http:// www.cgl.ucsf.edu/chimera)

More information

ENZYME KINETICS. Medical Biochemistry, Lecture 24

ENZYME KINETICS. Medical Biochemistry, Lecture 24 ENZYME KINETICS Medical Biochemistry, Lecture 24 Lecture 24, Outline Michaelis-Menten kinetics Interpretations and uses of the Michaelis- Menten equation Enzyme inhibitors: types and kinetics Enzyme Kinetics

More information

Supporting Information

Supporting Information Supporting Information Allosteric communication disrupted by small molecule binding to the Imidazole glycerol phosphate synthase protein-protein interface. Ivan Rivalta*,#, George P. Lisi #, Ning-Shiuan

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Figure S1. Secondary structure of CAP (in the camp 2 -bound state) 10. α-helices are shown as cylinders and β- strands as arrows. Labeling of secondary structure is indicated. CDB, DBD and the hinge are

More information

SUPPLEMENTARY FIGURES

SUPPLEMENTARY FIGURES SUPPLEMENTARY FIGURES Supplementary Figure 1 Protein sequence alignment of Vibrionaceae with either a 40-residue insertion or a 44-residue insertion. Identical residues are indicated by red background.

More information

Supporting Information

Supporting Information Supporting Information Control of methylglyoxal synthesis in Bacillus subtilis: Structural basis for the regulatory interaction of the methylglyoxal synthase MgsA with the carbon flux regulator Crh Achim

More information

for Molecular Biology and Neuroscience and Institute of Medical Microbiology, Rikshospitalet-Radiumhospitalet

for Molecular Biology and Neuroscience and Institute of Medical Microbiology, Rikshospitalet-Radiumhospitalet SUPPLEMENTARY INFORMATION TO Structural basis for enzymatic excision of N -methyladenine and N 3 -methylcytosine from DNA Ingar Leiros,5, Marivi P. Nabong 2,3,5, Kristin Grøsvik 3, Jeanette Ringvoll 2,

More information

Biomolecules: lecture 10

Biomolecules: lecture 10 Biomolecules: lecture 10 - understanding in detail how protein 3D structures form - realize that protein molecules are not static wire models but instead dynamic, where in principle every atom moves (yet

More information

Viewing and Analyzing Proteins, Ligands and their Complexes 2

Viewing and Analyzing Proteins, Ligands and their Complexes 2 2 Viewing and Analyzing Proteins, Ligands and their Complexes 2 Overview Viewing the accessible surface Analyzing the properties of proteins containing thousands of atoms is best accomplished by representing

More information

Structural biology and drug design: An overview

Structural biology and drug design: An overview Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved

More information

Supporting Information Converter domain mutations in myosin alter structural kinetics and motor function. Hershey, PA, MN 55455, USA

Supporting Information Converter domain mutations in myosin alter structural kinetics and motor function. Hershey, PA, MN 55455, USA Supporting Information Converter domain mutations in myosin alter structural kinetics and motor function Laura K. Gunther 1, John A. Rohde 2, Wanjian Tang 1, Shane D. Walton 1, William C. Unrath 1, Darshan

More information

Rational Design of Thermodynamic and Kinetic Binding Profiles by. Optimizing Surface Water Networks Coating Protein Bound Ligands

Rational Design of Thermodynamic and Kinetic Binding Profiles by. Optimizing Surface Water Networks Coating Protein Bound Ligands SUPPORTING INFORMATION Rational Design of Thermodynamic and Kinetic Binding Profiles by Optimizing Surface Water Networks Coating Protein Bound Ligands Stefan G. Krimmer,, Jonathan Cramer,, Michael Betz,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary materials Figure S1 Fusion protein of Sulfolobus solfataricus SRP54 and a signal peptide. a, Expression vector for the fusion protein. The signal peptide of yeast dipeptidyl aminopeptidase

More information

Build_model v User Guide

Build_model v User Guide Build_model v.2.0.1 User Guide MolTech Build_model User Guide 2008-2011 Molecular Technologies Ltd. www.moltech.ru Please send your comments and suggestions to contact@moltech.ru. Table of Contents Input

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature11524 Supplementary discussion Functional analysis of the sugar porter family (SP) signature motifs. As seen in Fig. 5c, single point mutation of the conserved

More information

Acta Cryst. (2017). D73, doi: /s

Acta Cryst. (2017). D73, doi: /s Acta Cryst. (2017). D73, doi:10.1107/s2059798317010932 Supporting information Volume 73 (2017) Supporting information for article: Designing better diffracting crystals of biotin carboxyl carrier protein

More information

Plan. Day 2: Exercise on MHC molecules.

Plan. Day 2: Exercise on MHC molecules. Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:

More information

Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner

Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features

More information

Supporting Information

Supporting Information Supporting Information Wiley-VCH 2006 69451 Weinheim, Germany Snapshots of the Reaction Mechanism of Matrix Metalloproteinases Ivano Bertini, *,1,2 Vito Calderone, 1 Marco Fragai, 1,3 Claudio Luchinat,

More information

Catalytic Mechanism of the Glycyl Radical Enzyme 4-Hydroxyphenylacetate Decarboxylase from Continuum Electrostatic and QC/MM Calculations

Catalytic Mechanism of the Glycyl Radical Enzyme 4-Hydroxyphenylacetate Decarboxylase from Continuum Electrostatic and QC/MM Calculations Catalytic Mechanism of the Glycyl Radical Enzyme 4-Hydroxyphenylacetate Decarboxylase from Continuum Electrostatic and QC/MM Calculations Supplementary Materials Mikolaj Feliks, 1 Berta M. Martins, 2 G.

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Table S1 Kinetic Analyses of the AMSH-LP mutants AMSH-LP K M (μm) k cat x 10-3 (s -1 ) WT 71.8 ± 6.3 860 ± 65.4 T353A 76.8 ± 11.7 46.3 ± 3.7 F355A 58.9 ± 10.4 5.33 ± 0.30 proximal S358A 75.1

More information

Supporting Information. Synthesis of Aspartame by Thermolysin : An X-ray Structural Study

Supporting Information. Synthesis of Aspartame by Thermolysin : An X-ray Structural Study Supporting Information Synthesis of Aspartame by Thermolysin : An X-ray Structural Study Gabriel Birrane, Balaji Bhyravbhatla, and Manuel A. Navia METHODS Crystallization. Thermolysin (TLN) from Calbiochem

More information

Supplementary figure 1. Comparison of unbound ogm-csf and ogm-csf as captured in the GIF:GM-CSF complex. Alignment of two copies of unbound ovine

Supplementary figure 1. Comparison of unbound ogm-csf and ogm-csf as captured in the GIF:GM-CSF complex. Alignment of two copies of unbound ovine Supplementary figure 1. Comparison of unbound and as captured in the GIF:GM-CSF complex. Alignment of two copies of unbound ovine GM-CSF (slate) with bound GM-CSF in the GIF:GM-CSF complex (GIF: green,

More information

BIOCHEMISTRY Course Outline (Fall, 2011)

BIOCHEMISTRY Course Outline (Fall, 2011) BIOCHEMISTRY 402 - Course Outline (Fall, 2011) Number OVERVIEW OF LECTURE TOPICS: of Lectures INSTRUCTOR 1. Structural Components of Proteins G. Brayer (a) Amino Acids and the Polypeptide Chain Backbone...2

More information

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,

More information

Data Quality Issues That Can Impact Drug Discovery

Data Quality Issues That Can Impact Drug Discovery Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,

More information

Biological Chemistry and Metabolic Pathways

Biological Chemistry and Metabolic Pathways Biological Chemistry and Metabolic Pathways 1. Reaction a. Thermodynamics b. Kinetics 2. Enzyme a. Structure and Function b. Regulation of Activity c. Kinetics d. Inhibition 3. Metabolic Pathways a. REDOX

More information

Supplementary Materials for

Supplementary Materials for www.sciencesignaling.org/cgi/content/full/5/243/ra68/dc1 Supplementary Materials for Superbinder SH2 Domains Act as Antagonists of Cell Signaling Tomonori Kaneko, Haiming Huang, Xuan Cao, Xing Li, Chengjun

More information

Introduction to Metabolism (Or Energy Management) Chapter 8

Introduction to Metabolism (Or Energy Management) Chapter 8 Introduction to Metabolism (Or Energy Management) Chapter 8 Metabolism of the chemical reactions in the organism Building up molecules Breaking down molecules Managing energy and materials Route to end-product

More information

Automated identification of functional dynamic contact networks from X-ray crystallography

Automated identification of functional dynamic contact networks from X-ray crystallography 1 Automated identification of functional dynamic contact networks from X-ray crystallography Henry van den Bedem, Gira Bhabha, Kun Yang, Peter E. Wright and James S. Fraser Supplementary Figure 1 Supplementary

More information

Chapter 8: An Introduction to Metabolism

Chapter 8: An Introduction to Metabolism Chapter 8: An Introduction to Metabolism Key Concepts 8.1 An organism s metabolism transforms matter and energy, subject to the laws of thermodynamics 8.2 The free-energy change of a reaction tells us

More information

Introduction to" Protein Structure

Introduction to Protein Structure Introduction to" Protein Structure Function, evolution & experimental methods Thomas Blicher, Center for Biological Sequence Analysis Learning Objectives Outline the basic levels of protein structure.

More information

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules

More information

Expanded View Figures

Expanded View Figures The EMBO Journal Structure of a Dm peptide bound to the OT module Tobias Raisch et al Expanded View Figures A Hs Dm 262 297 685 8 HEAT HEAT MIF4G 9BD 1SHD 761 91 193 169 1152 1317 16 1376 1467 HEAT HEAT

More information

THE CRYSTAL STRUCTURE OF THE SGT1-SKP1 COMPLEX: THE LINK BETWEEN

THE CRYSTAL STRUCTURE OF THE SGT1-SKP1 COMPLEX: THE LINK BETWEEN THE CRYSTAL STRUCTURE OF THE SGT1-SKP1 COMPLEX: THE LINK BETWEEN HSP90 AND BOTH SCF E3 UBIQUITIN LIGASES AND KINETOCHORES Oliver Willhoft, Richard Kerr, Dipali Patel, Wenjuan Zhang, Caezar Al-Jassar, Tina

More information

Substrate and Cation Binding Mechanism of Glutamate Transporter Homologs Jensen, Sonja

Substrate and Cation Binding Mechanism of Glutamate Transporter Homologs Jensen, Sonja University of Groningen Substrate and Cation Binding Mechanism of Glutamate Transporter Homologs Jensen, Sonja IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you

More information

Table S1. Overview of used PDZK1 constructs and their binding affinities to peptides. Related to figure 1.

Table S1. Overview of used PDZK1 constructs and their binding affinities to peptides. Related to figure 1. Table S1. Overview of used PDZK1 constructs and their binding affinities to peptides. Related to figure 1. PDZK1 constru cts Amino acids MW [kda] KD [μm] PEPT2-CT- FITC KD [μm] NHE3-CT- FITC KD [μm] PDZK1-CT-

More information

Stabilizing the CH2 domain of an Antibody by Engineering in an Enhanced Aromatic Sequon

Stabilizing the CH2 domain of an Antibody by Engineering in an Enhanced Aromatic Sequon Stabilizing the CH2 domain of an Antibody by Engineering in an Enhanced Aromatic Sequon Wentao Chen,, Leopold Kong, Stephen Connelly, Julia M. Dendle,, Yu Liu,, Ian A. Wilson,#, Evan T. Powers, *, Jeffery

More information

Lecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp

Lecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp Lecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp. 216-225 Updated on: 2/4/07 at 9:00 pm Key Concepts Kinetics is the study of reaction rates. Study of enzyme kinetics

More information

BSc and MSc Degree Examinations

BSc and MSc Degree Examinations Examination Candidate Number: Desk Number: BSc and MSc Degree Examinations 2018-9 Department : BIOLOGY Title of Exam: Molecular Biology and Biochemistry Part I Time Allowed: 1 hour and 30 minutes Marking

More information

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput

More information

What is Protein-Ligand Docking?

What is Protein-Ligand Docking? MOLECULAR DOCKING Definition: What is Protein-Ligand Docking? Computationally predict the structures of protein-ligand complexes from their conformations and orientations. The orientation that maximizes

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Data collection Supplementary Table 1 Statistics of data collection, phasing and refinement Native Se-MAD Space group P2 1 2 1 2 1 P2 1 2 1 2 1 Cell dimensions a, b, c (Å) 50.4, 94.2, 115.4 49.8, 94.2,

More information

of the Guanine Nucleotide Exchange Factor FARP2

of the Guanine Nucleotide Exchange Factor FARP2 Structure, Volume 21 Supplemental Information Structural Basis for Autoinhibition of the Guanine Nucleotide Exchange Factor FARP2 Xiaojing He, Yi-Chun Kuo, Tyler J. Rosche, and Xuewu Zhang Inventory of

More information

Nonlinear QSAR and 3D QSAR

Nonlinear QSAR and 3D QSAR onlinear QSAR and 3D QSAR Hugo Kubinyi Germany E-Mail kubinyi@t-online.de HomePage www.kubinyi.de onlinear Lipophilicity-Activity Relationships drug receptor Possible Reasons for onlinear Lipophilicity-Activity

More information

ENZYME MECHANISMS, PROTEASES, STRUCTURAL BIOLOGY

ENZYME MECHANISMS, PROTEASES, STRUCTURAL BIOLOGY Supplementary Information SUBJECT AREAS: ENZYME MECHANISMS, PROTEASES, STRUCTURAL BIOLOGY Correspondence and requests for materials should be addressed to N.T. (ntanaka@pharm.showa-u.ac.jp) or W.O. (owataru@vos.nagaokaut.ac.jp)

More information

Supporting Information

Supporting Information Supporting Information Reaction Mechanism of Adenylyltransferase DrrA from Legionella pneumophila Elucidated by Time-Resolved Fourier Transform Infrared Spectroscopy Konstantin Gavriljuk, Jonas Schartner,

More information

Electronic Supplementary Information Effective lead optimization targeted for displacing bridging water molecule

Electronic Supplementary Information Effective lead optimization targeted for displacing bridging water molecule Electronic Supplementary Material (ESI) for Physical Chemistry Chemical Physics. This journal is the Owner Societies 2018 Electronic Supplementary Information Effective lead optimization targeted for displacing

More information

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction Fondamenti di Chimica Farmaceutica Computer Chemistry in Drug Research: Introduction Introduction Introduction Introduction Computer Chemistry in Drug Design Drug Discovery: Target identification Lead

More information

Supplementary Figure 1. Biochemical and sequence alignment analyses the

Supplementary Figure 1. Biochemical and sequence alignment analyses the Supplementary Figure 1. Biochemical and sequence alignment analyses the interaction of OPTN and TBK1. (a) Analytical gel filtration chromatography analysis of the interaction between TBK1 CTD and OPTN(1-119).

More information

[Urea] (M) k (s -1 )

[Urea] (M) k (s -1 ) BMB178 Fall 2018 Problem Set 1 Due: 10/26/2018, noon Office hour: 10/25/2018, SFL GSR218 7 9 pm Problem 1. Transition state theory (20 points): Consider a unimolecular reaction where a substrate S is converted

More information

Structure and evolution of the spliceosomal peptidyl-prolyl cistrans isomerase Cwc27

Structure and evolution of the spliceosomal peptidyl-prolyl cistrans isomerase Cwc27 Acta Cryst. (2014). D70, doi:10.1107/s1399004714021695 Supporting information Volume 70 (2014) Supporting information for article: Structure and evolution of the spliceosomal peptidyl-prolyl cistrans isomerase

More information

Supplementary Information: Table S1. Potential energy and essential dynamics (ED) analysis of the MD simulations of the Bcl-2 complexes under study.

Supplementary Information: Table S1. Potential energy and essential dynamics (ED) analysis of the MD simulations of the Bcl-2 complexes under study. Supplementary Information: Table S1. Potential energy and essential dynamics (ED) analysis of the MD simulations of the Bcl-2 complexes under study. Bcl2 and complex Potential energy (kj/mol) ED 2D projection

More information

Supporting Information

Supporting Information Supporting Information Discovery and optimization of a selective ligand for the Switch/Sucrose Non-Fermenting-related bromodomains of Polybromo protein-1 by the use of virtual screening and hydration analysis.

More information

Performing a Pharmacophore Search using CSD-CrossMiner

Performing a Pharmacophore Search using CSD-CrossMiner Table of Contents Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Searching with a Pharmacophore... 4 Performing a Pharmacophore Search using CSD-CrossMiner Version 2.0

More information

Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S.

Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S. Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G219S. Min Liu@&*, Samantha A. Bender%*, Gregory D Cuny@, Woody Sherman, Marcie Glicksman@ Soumya

More information

CHAPTER 3. Pharmacophore modelling studies:

CHAPTER 3. Pharmacophore modelling studies: CHAPTER 3 Pharmacophore modelling studies: 3.1 Introduction: According to Langer & Wolber (2004), the key goal of computer-aided molecular design methods in medicinal chemistry is to reduce the time and

More information

4. What is the general expression Keq (the equilibrium constant) in terms of product and reactant concentration? tell us about the enzyme.

4. What is the general expression Keq (the equilibrium constant) in terms of product and reactant concentration? tell us about the enzyme. Section 8 Enzyme Kinetics Pre-Activity Assignment 1. Produce a reading log for the sections in your text that discuss the Michaelis-Menten equation and including kcat. 2. Focus on the derivation of the

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Results DNA binding property of the SRA domain was examined by an electrophoresis mobility shift assay (EMSA) using synthesized 12-bp oligonucleotide duplexes containing unmodified, hemi-methylated,

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Table of Contents Page Supplementary Table 1. Diffraction data collection statistics 2 Supplementary Table 2. Crystallographic refinement statistics 3 Supplementary Fig. 1. casic1mfc packing in the R3

More information

Dr. Yonca Yuzugullu PERG (Protein Engineering Research Group)

Dr. Yonca Yuzugullu PERG (Protein Engineering Research Group) Dr. Yonca Yuzugullu PERG (Protein Engineering Research Group) BSc, 1997 Ankara University, Turkey PhD, 2010 Middle East Technical University, Turkey Lecturer in Department of Biology Kocaeli University,

More information

Matthias W. Büttner, Jennifer B. Nätscher, Christian Burschka, and Reinhold Tacke *

Matthias W. Büttner, Jennifer B. Nätscher, Christian Burschka, and Reinhold Tacke * Development of a New Building Block for the Synthesis of Silicon-Based Drugs and Odorants: Alternative Synthesis of the Retinoid Agonist Disila-bexarotene Matthias W. Büttner, Jennifer B. Nätscher, Christian

More information

Structural basis for catalytically restrictive dynamics of a high-energy enzyme state

Structural basis for catalytically restrictive dynamics of a high-energy enzyme state Supplementary Material Structural basis for catalytically restrictive dynamics of a high-energy enzyme state Michael Kovermann, Jörgen Ådén, Christin Grundström, A. Elisabeth Sauer-Eriksson, Uwe H. Sauer

More information

Homology modeling of Ferredoxin-nitrite reductase from Arabidopsis thaliana

Homology modeling of Ferredoxin-nitrite reductase from Arabidopsis thaliana www.bioinformation.net Hypothesis Volume 6(3) Homology modeling of Ferredoxin-nitrite reductase from Arabidopsis thaliana Karim Kherraz*, Khaled Kherraz, Abdelkrim Kameli Biology department, Ecole Normale

More information

Computational Biology 1

Computational Biology 1 Computational Biology 1 Protein Function & nzyme inetics Guna Rajagopal, Bioinformatics Institute, guna@bii.a-star.edu.sg References : Molecular Biology of the Cell, 4 th d. Alberts et. al. Pg. 129 190

More information

Design of a Novel Globular Protein Fold with Atomic-Level Accuracy

Design of a Novel Globular Protein Fold with Atomic-Level Accuracy Design of a Novel Globular Protein Fold with Atomic-Level Accuracy Brian Kuhlman, Gautam Dantas, Gregory C. Ireton, Gabriele Varani, Barry L. Stoddard, David Baker Presented by Kate Stafford 4 May 05 Protein

More information

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP) Joana Pereira Lamzin Group EMBL Hamburg, Germany Small molecules How to identify and build them (with ARP/wARP) The task at hand To find ligand density and build it! Fitting a ligand We have: electron

More information